MonkeyPox
Meeting category
Program Language
English
Meeting type
Virtual Meeting

Monkeypox Clinical Forum 2022

Related Enduring Materials

Enduring Materials

The presentation videos and slides for speakers’ lectures are made available, provided that they have granted us permission to do so.

Tuesday, 13 September 2022 -
Case Recognition and Case Definition in the Multi-country Outbreak
Chloe Orkin, MBChB, FRCP, MD
Queen Mary University of London, United Kingdom
Comparing the Epidemiology and Clinical Presentation of Monkeypox in Nigeria and the Global North
Dimie Ogoina, MBBS, FWACP, FMCP-Infectious Diseases, FACP, FIDSA
Niger Delta University Teaching Hospital (NDUTH), Niger Delta University, and Nigerian Infectious Diseases Society, Nigeria
Monkeypox Treatment and Prevention
Daniel Kuritzkes, MD
Brigham and Women's Hospital / Harvard Medical School, United States
Overview
Image
MonkeyPox Teaser
What's New
About this Program

Several countries in West and Central Africa have been reporting human monkeypox infection since the 1970s but despite this, it has remained a neglected tropical infection that has been underfunded and under-researched. Sporadic exported cases outside of Africa have occurred several times over the years with very short chains of (mainly household or HCW) transmission beyond the index case. This situation changed in early May 2022 when the first cases of this global outbreak were reported to the WHO.

Since then, there have been near-simultaneous outbreaks in multiple countries which now affect at least all 6 WHO regions and at least 79 countries. The WHO declared the situation a PHIEC in late July. The outbreaks are occurring almost exclusively in sexually active gay and bisexual men who have sex with men (GBMSM). Infections in previously affected African countries are now accounting for 2% of the globally reported cases.

There is an urgent need for education for clinicians in most countries who may never have seen or treated anyone with human monkeypox infection. There are many unanswered questions about transmission, asymptomatic disease, treatment, and vaccine efficacy for pre- and post-exposure prophylaxis, not to mention the evolution of a new phylogenetic classification nomenclature.

This program will aim to provide rapid education for those caring for people with human monkeypox infection from the perspective of clinicians previously and newly experienced with the disease.

Program Director
General Information
Who Should Attend?
-Healthcare providers involved in the care of people diagnosed with Monkeypox;
-Infectious disease clinicians;
-Clinical virologists;
-Primary care physicians;
-Microbiologists; and
-Specialized nurses.
Learning Objectives
After attending this webinar, participants will be able to:

-Outline our current knowledge of the epidemiology of the Monkeypox outbreak;
-Categorize the various clinical symptoms for case recognition/definition; and
-Reflect on the therapeutical options for treatment and prevention.
Practical Information 
Certificate of Attendance
A certificate of attendance will be sent to you after successfully completing the program and post-meeting survey.
Language
The official language of the meeting is English. Translation will not be provided.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Program Director
Program Chairs
Support
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and community representatives involved in Monkeypox.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Federica Ressa at federica@amededu.com or call +31 30 230 7140.
 

Endorsers
Become an Endorser

If you would like your organization to support the Monkeypox Clinical Forum 2022 as an endorser or media partner, please contact Ms. Vicky Cheng at vicky.cheng@amededu.com.

Endorsers

The Monkeypox Clinical Forum 2022 was endorsed by the following organizations: